BRIEF — UCB Annouces FDA Approval For Zilbrysq Autoinjector Self — Administration For Adults Living With Generalized Myasthenia Gravis
Oct 16 (Reuters) — Ucb SA: Announces U.s. Fda Approval For Zilbrysq (Zilucoplan) Autoinjector Self-administration For Adults Living With Generalized Myasthenia Gravis Prior To Autoinjector's Approval, Zilbrysq Was Available As A Self-administered Prefilled Syringe (Pfs) Expects Autoinjector To Be Available Commercially